The global breast imaging market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The market was valued at $3.7 billion in 2019 and is anticipated to reach $5.6 billion in 2026. The global breast imaging industry is comprised of several players providing imaging technologies for breast cancer. These players across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers & acquisitions, new imaging technology launch, and technology innovation to remain competitive in the marketplace. For instance, in December 2020, Hologic, Inc., a medical technology company focused on women’s health, has announced that it has received approval from the US FDA for Genius AI detection technology. The Genius AI software is designed to assist radiologists to detect potential cancers in the breast tomosynthesis images. This software aids in the identification and early detection of breast cancer when used with the Genius 3D Mammography exam.
To Request a Sample of our Report on Breast Imaging Market: https://www.omrglobal.com/request-sample/breast-imaging-market
In April 2020, Dilon Technologies Inc., a breast cancer treatment and diagnosis company has acquired the assets of Dune Medical. The device named MarginProbe is the Dune medicals technology, and this allows surgeons to remove additional tissues, assisting to reduce avoidable surgeries. Dillon offers only FDA-approved devices which also includes, Navigator Gamma Probes, a device used for radio-guided lymphatic mapping and tumor localization across the globe. Apart from it, in December 2020, Smart Breast Corp., a company involved in breast cancer screening and detection, has announced the acquisition of Molecular Breast Imaging (MBI) assets from Dilon Technologies, Inc. Thus, the various imaging technologies developed by the key players for breast, and FDA approvals for the innovations in the breast imaging technologies are driving the growth of the global breast imaging market during the forecast period.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Ionizing Technologies
- By Non-Ionizing Technologies
- By Screening Methods
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-Aurora Healthcare US Corp., FUJIFILM Holdings America Corp., GE Healthcare, Hologic Inc., Siemens Healthcare GmbH, Koninklijke Philips N.V., Bracco Imaging S.P.A, among others
Key Strategies Adopted by Major Players:
- In April 2020, Bracco Imaging, a diagnostic imaging company, has announced a new initiative named BRACCO CARES. It is a non-promotional program to support the community across the globe during the COVID-19 pandemic. BRACCO CARES is an imaging community to assist the diagnosis, treatment, and care of patients.
- In November 2018, CMR Naviscan Corp., a technology solution for high-resolution diagnostic imaging, has signed an agreement with Mayo Clinic. Both the companies will together develop technologies for breast cancer such as licensed Molecular Breast Imaging (MBI) intellectual property, which is used in the CMR Molecular Imaging LumaGEMMolecular Breast Imaging (MBI) System, manufactured and distributed by CMR Naviscan.
(Get 15% Discount on Buying this Report)
A full Report of Breast Imaging Market is Available at: https://www.omrglobal.com/industry-reports/breast-imaging-market
Global Breast Imaging Market Report Segment
By Ionizing Technologies
- Analog Mammography
- 3D Breast Tomosynthesis
- Cone Beam Computed Tomography (CB-CT)
- Positron Emission Mammography (PEM)
- Molecular Breast Imaging
By Non-Ionizing Technologies
- Breast MRI
- Breast Ultrasound
- Optical Imaging
- Breast Thermography
By Screening Methods
- Symptomatic Imaging
- Asymptomatic Imaging
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
